The diagnostic criteria of ASS are available in chart 1. 3 The most common clinical manifestations of ASS include: inflammatory myositis (>90%), Interstitial Lung Disease (ILD) (60%), non-erosive arthritis (50%), Raynaud phenomenon (40%), "mechanic's hand" (30%), and fever (20%). 6 The main differential diagnoses include progressive systemic sclerosis, dermatomyositis/polymyositis, and overlap syndromes.
The autoantibodies involved in the disease (in order of frequency) and the amino acids that are targets of RNAt-synthetase are: anti-Jo1 (histidine), anti-PL-12 (alanine), anti-PL-7 (threonine),
anti-OJ (isoleucine), anti-KS (asparagine), anti-EJ (glycine), and anti-ZO (phenylalanine). The phenotype of the disease varies accord-
ing to the expressed autoantibody. 7 Myopathy occurs more often in patients with anti-Jo-1 or anti-PL-7; anti-Jo-1 is related to the more extreme cases of arthritis and "mechanic's hand", while anti-PL-7
is associated with the presence of heliotrope; anti-PL-12 with the higher rates of Raynaud phenomenon; and anti-PL-12, anti-KS, and
anti-OJ with cases of isolated ILD. 8 To date, no randomized studies have evaluated the therapeutic effectiveness of ASS. 7 The treatment of choice is prednisone at an initial dose of 1mg/Kg/day. Other possibilities described include: tacrolimus, mycophenolate mofetil, immunoglobin, azathioprine, methotrexate, cyclophosphamide, and cyclosporine. 7 Rituximab was reported to be efficient in the treatment of refractory myositis, but did not influence the evolution of ILD or the loss of The prognosis of ASS is quite limited when compared to other inflammatory myopathies without antisynthetase antibodies, which results mainly from greater ILD resistance to corticotherapy, evolving into the need for a lung transplant. 1, 3, 10 Our patient was submitted to oral corticotherapy associated with pulse therapy using cyclophosphamide and, later, with mycophenolate mofetil and rituximab, without, to date, fully controlling the lung disease.
Dermatologists must pay attention to myopathic and/or lung conditions that present the Raynaud phenomenon, nail dystrophy, repeated periungual/paronychia erythema, atrophy of the digital pulp, and "mechanic's hand" peeling, in an attempt to collaborate with an early diagnosis of the disease with a limited prognosisq
